LabEx Medalis

Prokineticin receptor 1 as a novel suppressor of preadipocyte proliferation and differentiation to control obesity.

Szatkowski C., Vallet J., Dormishian M., Messaddeq N., Valet P., Boulberdaa M, Metzger D, Chambon P, Nebigil C.G.

Plos One 2013;DOI:10.1371

DOI 

Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions.

Dormishian M., Türkeri G. , Urayama K., Nguyen TL., Boulberdaa M., Messaddeq N., Renault G., Henrion D. and Nebigil C. G.

J Am Heart Assoc. 2013 Oct 23;2(5):e000411

DOI

Prohibitin ligands in cell death and survival: mode of action and therapeutic potential.

Thuaud F, Ribeiro N, Nebigil CG, Désaubry L.

Chem Biol. 2013;20(3):316-3

DOI

Flavaglines as potent Anticancer and Cytoprotective Agents

Nigel Ribeiro †, Frédéric Thuaud †, Yohann Bernard , Christian Gaiddon ‡, Thierry Cresteil §, Audrey Hild #, Etienne C. Hirsch #, Patrick Pierre Michel #, Canan G. Nebigil , and Laurent Désaubry *†

† Therapeutic Innovation Laboratory, UMR7200, CNRS/Université de Strasbourg, Illkirch, France
‡ Molecular Signaling and Neurodegeneration, UMRS692, INSERM/Université de Strasbourg, France
§ Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Gif-sur-Yvette, France
Université Pierre et Marie Curie-Paris 6, CR-ICM, UMR-S975, Paris, France
INSERM, UMR 975, Paris, France
# CNRS, UMR 7225, Paris, France
Biotechnology and Cell Signaling Laboratory, UMR 7242, CNRS/Université de Strasbourg, Illkirch, France

J. Med. Chem., Article ASAP
Publication Date (Web): October 16, 2012

DOI

Vous êtes ici : Publications RCPG et cardiobiologie